FibroGen(FGEN) - 2025 Q4 - Earnings Call Presentation

Fourth Quarter and Full Year 2025 Financial Results March 16, 2026 Forward-Looking Statements This presentation contains forward-looking statements regarding Kyntra Bio's strategy, future plans and prospects, including statements regarding its commercial products and clinical programs and those of its partners Fortis and UCSF. These forward-looking statements include, but are not limited to, statements regarding the efficacy, safety, and potential clinical or commercial success of Kyntra Bio products and pr ...